Abiopharma

News list

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

FDA Approval
Dec. 31, 2025, 13:45 UTC

Labeling changes approved for AUROLIFE PHARMA LLC. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025

Full text

Register to leave comments
There are no comments here yet...